Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer165
Surgical Management of Melanoma: Advances and Updates107
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review92
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review78
New Developments in VHL-Associated Neuroendocrine Neoplasms59
NRG1 Fusions: The New Kid on the Block49
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas48
Immunotherapy in Biliary Tract Cancers: Where Are We?48
Brain Prehabilitation for Oncologic Surgery44
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting42
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan40
Surgical Stress and Cancer Progression: New Findings and Future Perspectives39
AXL Inhibitors: Status of Clinical Development38
Current Trends and Challenges of Microbiome Research in Prostate Cancer38
Cellular Therapy in NSCLC: Between Myth and Reality38
The Difficult Airway in Patients with Cancer37
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites36
Head and Neck Mucosal Melanoma: Where Are We Now?36
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients35
The Microbiome in Advanced Melanoma: Where Are We Now?34
An Overview of Angiogenesis in Bladder Cancer31
Appendiceal Neuroendocrine Neoplasms: an Update for 202331
Targeting the PI3K Pathway in Gynecologic Malignancies31
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review30
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations28
Proton Therapy in The Treatment of Head And Neck Cancers- Review28
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours28
CAR-T Therapies in Solid Tumors: Opportunities and Challenges26
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?26
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer25
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations25
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question25
Geographical Disparities in Colorectal Cancer in Canada: A Review24
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews24
Development of Effective Siglec-9 Antibodies Against Cancer23
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma23
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)23
Vascular Inflammation, Cancer, and Cardiovascular Diseases22
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review22
Surgery for Recurrent Epithelial Ovarian Cancer22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Current Management of Neuroendocrine Tumour Liver Metastases21
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets21
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
Evolving Treatment Approaches to Mucosal Melanoma21
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?21
Management of Peripheral T-cell Lymphomas and the Role of Transplant20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Current Diagnostic Tools for Breast Cancer-Related Lymphedema20
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging20
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review19
History of Leukemia, Revisited19
Elderly Rectal Cancer: An Updated Review19
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review19
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer19
Current Status on Management of Primary Plasma Cell Leukemia19
Multimodality Therapies for Localized Prostate Cancer18
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy18
Epidemiology of Cancer in Older Adults: A Systematic Review18
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers17
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives16
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis16
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade16
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Lymphatic Interventions in the Cancer Patient15
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment15
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL15
CDK4/6 inhibitors: The Devil is in the Detail15
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas15
CAR T-cell Therapy for Central Nervous System Lymphoma15
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers14
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab14
Cardio-Oncology in Childhood: State of the Art14
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer14
Advances in Treatment of Waldenström Macroglobulinemia14
Integrative Geriatric Oncology: A Review of Current Practices14
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer14
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine14
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes13
Surviving Burnout as an Oncologist13
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism13
0.059386968612671